Tele: 561.316.3330
Breaking Medical Device News

Wednesday, October 20, 2021

MEDICAL DEVICE NEWS MAGAZINE

A DIGITAL PUBLICATION FOR THE PRACTICING MEDICAL SPECIALIST, INDUSTRY EXECUTIVE AND INVESTOR
HomeGynesonics

Gynesonics

Gynesonics Announces First Office-Based Sonata Treatment Procedure in the State of Texas

Sonata Treatment is a breakthrough alternative to hysterectomy & myomectomy, & can treat a wider range of fibroid types, sizes, & locations than hysteroscopic myomectomy. 

Gynesonics Announces Publication of Clinical Study Analysis Demonstrating Effectiveness of the Sonata System in Treating Submucous and Large Symptomatic Uterine Fibroids

The article is an analysis of a subgroup of patients with submucous or large fibroids from two previously published multicenter prospective clinical trials (FAST-EU and SONATA) of transcervical fibroid ablation (TFA) with the Sonata System.

Gynesonics Announces Publication of CHOICES

Sonata demonstrates significant advantages in reducing procedure time, length of stay and procedure-related costs compared to myomectomy.

Gynesonics Reports Sonata System Assists Facilities Impacted by the COVID-19 Pandemic in Restarting Elective Gynecologic Procedures

Sonata integrates the first and only intrauterine ultrasound system with a proprietary advanced radiofrequency ablation device to treat symptomatic fibroids in a transcervical, incision-free, uterus-preserving manner.

Next Generation Sonata® System 2.1 Receives FDA Market Clearance

The new advances in Sonata® System 2.1 include a new integrated treatment device design that enables all procedure steps to be performed on the sterile field and in the palm of the physician’s hand.

By using this website you agree to accept Medical Device News Magazine Privacy Policy